RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,245,836 | -0.8% | 141,585 | -28.7% | 0.00% | 0.0% |
Q2 2023 | $3,272,325 | +371333.0% | 198,443 | +301.7% | 0.00% | – |
Q1 2023 | $881 | -36.3% | 49,404 | +4.0% | 0.00% | -100.0% |
Q4 2022 | $1,383 | -99.9% | 47,491 | +17.9% | 0.00% | – |
Q3 2022 | $987,000 | +477.2% | 40,290 | -2.2% | 0.00% | – |
Q2 2022 | $171,000 | -92.4% | 41,205 | -79.4% | 0.00% | -100.0% |
Q1 2022 | $2,250,000 | +11.4% | 199,950 | -1.2% | 0.00% | 0.0% |
Q4 2021 | $2,020,000 | -27.7% | 202,378 | -5.4% | 0.00% | 0.0% |
Q3 2021 | $2,794,000 | -43.0% | 213,982 | -14.5% | 0.00% | 0.0% |
Q2 2021 | $4,900,000 | +50.3% | 250,256 | +63.3% | 0.00% | 0.0% |
Q1 2021 | $3,260,000 | -18.8% | 153,269 | +13.4% | 0.00% | 0.0% |
Q4 2020 | $4,017,000 | +54.9% | 135,106 | +12.9% | 0.00% | 0.0% |
Q3 2020 | $2,593,000 | -1.3% | 119,659 | +1.6% | 0.00% | 0.0% |
Q2 2020 | $2,626,000 | +61.9% | 117,777 | +10.5% | 0.00% | 0.0% |
Q1 2020 | $1,622,000 | -29.2% | 106,596 | +6.9% | 0.00% | 0.0% |
Q4 2019 | $2,290,000 | +43.9% | 99,741 | +35.3% | 0.00% | 0.0% |
Q3 2019 | $1,591,000 | -6.3% | 73,716 | -4.5% | 0.00% | 0.0% |
Q2 2019 | $1,698,000 | – | 77,185 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |